BIOP Green Gas to Control Biometano Energy

BIOP Green Gas, an Austrian company of the Biogest group, manufacturer of biomethane and biogas plants, 25% owned by the Eiffel Gaz Vert fund managed by Eiffel Investment Group since 2022, has completed the purchase of the majority of the share capital of Biometano Energy srl.

Biometano is a company active in the sector and owner of the biomethane production plant located in the municipality of Collarmele (L’Aquila) and whose construction had been opposed in recent years by the municipal administrations of Collarmele and the neighboring San Benedetti dei Marsi and Pescina.

According to the Chamber of Commerce register, Biogest has acquired 85% of the capital of Biometano Energy, while the remaining 15% is in the hands of the Italian Alpalux Energy srl , based in Avezzano (L’Aquila). In the context of the operation, Biop Green Gas was assisted by the law firm Elli Falsoni of Milan.

For Biogest, this is the group’s first biomethane plant in Italy. The operation was announced last November 2023.

The plant converts 73,000 tons/year of chicken manure and vegetable waste (fennel, carrots and potatoes) into 500 Nm3/h of biomethane, using Biogest’s PowerRing and PowerDigest technologies. The project includes a CO2 liquefaction unit.

BIOP owns and operates 6 biogas and biomethane plants in the Czech Republic, the UK and France

Romeo D’Amore, founder of Alpalux Energy, said at the start of construction in late 2023: I couldn’t be more excited about the progress and success of BIOP’s first project in Collarmele. This is truly a milestone for both the Biogest Group and the renewable energy sector as a whole. This project demonstrates BIOP and Alpalux Energy’s commitment to sustainable and innovative solutions. I can’t wait to see our first green gas production.”

Alessandro Armani , senior sales manager Biogest, added: “The project represents a significant step forward in our mission to create a greener and more sustainable future. I am confident that BIOP’s innovative approach will continue to lead the way in cleaner energy solutions and set new industry standards. Congratulations to the entire BIOP and Alpalux Energy team for their hard work and dedication in bringing this project to life!”

BIOP owns and operates 6 biogas and biomethane plants in the Czech Republic, the UK and France. It has over 20 projects in the pipeline across Europe and the US, aiming to maintain operations in key biogas regions. These green gas projects are designed with Biogest technology, which has been tried and tested in over 180 biogas plant projects worldwide, generating electricity or biomethane.

__

(Featured image by Julia Koblitz via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Be Beez. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us